BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29532622)

  • 1. Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer.
    Qian B; Wang X; Mao C; Jiang Y; Shi Y; Chen L; Liu S; Wang B; Pan S; Tao Y; Shi H
    Thorac Cancer; 2018 May; 9(5):589-597. PubMed ID: 29532622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
    Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
    Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.
    Luo J; Tang L; Zhang J; Ni J; Zhang HP; Zhang L; Xu JF; Zheng D
    Tumour Biol; 2014 Nov; 35(11):11541-9. PubMed ID: 25129441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
    Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
    Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
    Lin L; Gu ZT; Chen WH; Cao KJ
    Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
    Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
    Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC01433/miR-2116-3p/MYC Feedback Loop Promotes Cell Proliferation, Migration, and the Epithelial-Mesenchymal Transition in Breast Cancer.
    Wu M; Wu W; Ding J; Yang J
    Cancer Biother Radiopharm; 2019 Aug; 34(6):388-397. PubMed ID: 30939038
    [No Abstract]   [Full Text] [Related]  

  • 11. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition.
    Li N; Gao WJ; Liu NS
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2075-2086. PubMed ID: 28537678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer.
    Cheng D; Bao C; Zhang X; Lin X; Huang H; Zhao L
    Biomed Pharmacother; 2018 Nov; 107():1540-1547. PubMed ID: 30257372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer.
    Han W; Du X; Liu M; Wang J; Sun L; Li Y
    Int J Biol Macromol; 2019 Jan; 121():270-278. PubMed ID: 30287374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.
    Yu PF; Kang AR; Jing LJ; Wang YM
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):993-1002. PubMed ID: 29509247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways.
    Tong L; Wu W
    Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p.
    Lu G; Zhang Y
    PLoS One; 2020; 15(2):e0229118. PubMed ID: 32092085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells.
    Li K; Sun D; Gou Q; Ke X; Gong Y; Zuo Y; Zhou JK; Guo C; Xia Z; Liu L; Li Q; Dai L; Peng Y
    Cancer Lett; 2018 Apr; 420():80-90. PubMed ID: 29409808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
    He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
    J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.